Esophageal peroral endoscopic myotomy (POEM) for treatment of esophagogastric junction outflow obstruction: results from the first prospective trial

Abstract

Background and study aims Esophagogastric junction outflow obstruction (EGJOO) is a rare esophageal dysmotility disease that is characterized by elevated integrated relaxation pressuse (IRP) with evidence of preserved peristalsis. The role of peroral endoscopic myotomy (POEM) in management of EGJOO is currently unknown.

Patients and methods This is a prospective trial conducted in a single US tertiary care center from June 2015 to June 2019. Symptomatic patients, diagnosed with EGJOO on both HRM and endoluminal functional lumen imaging probe (EndoFLIP), who were eligible for POEM were recruited. Primary outcome was clinical success, defined as Eckardt score (ES) ≤ 3, at 6 months post-POEM. Other outcomes included dysphagia score, quality of life as measured by 36-item Short Form health survey scales (SF-36), post-POEM HRM, EndoFLIP, and pH measurements, and adverse events.

Results A total of 15 patients (51.8 yr. 9 F) with EGJOO underwent POEM. Pre-POEM mean IRP on HRM and Distensibility index (DI) on EndoFLIP were 24.3 ± 2.2 mmHg and 1.1 ± 0.6 mm²/mmHg, respectively. Clinical success was achieved in 93 % at 6 months post-POEM. There was significant decrease in IRP (-17.6 mmHg) post-POEM. There was significant improvement at 6 months in two of the SF-36 subscales. Ten patients underwent post-POEM pH testing, seven of whom had abnormal DeMeester score. Seven patients underwent EGD evaluation revealing esophagitis in five (2 Los Angeles grade A and 3 grade B).

Conclusions POEM offers a high clinical success rate for patients with EGJOO confirmed by impedance planimetry.

Publikationsverlauf

Eingereicht: 25. März 2020

Angenommen: 11. Mai 2020

Artikel online veröffentlicht:
31. August 2020

• References

• 1 Triadafilopoulos G, Clarke JO. Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification. BMJ Open Gastroenterol 2018; 5: e000210
• 2 Kahrilas PJ, Bredenoord AJ, Fox M. et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27: 160-174
• 3 Scherer JR, Kwiatek MA, Soper NJ. et al. Functional esophagogastric junction obstruction with intact peristalsis: a heterogeneous syndrome sometimes akin to achalasia. J Gastrointest Surg 2009; 13: 2219-2225
• 4 Kahrilas PJ, Boeckxstaens G. The spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometry. Gastroenterology 2013; 145: 954-965
• 5 The Chicago Classification of Esophageal Motility Disorders, v3.0. Neurogastroenterol Motil 2015; 27: 160-174
• 6 Garbarino S, von Isenburg M, Fisher DA. et al. Management of functional esophagogastric junction outflow obstruction: a systematic review. J Clin Gastroenterol 2020; 54: 35-42
• 7 Filicori F, Dunst CM, Sharata A. et al. Long-term outcomes following POEM for non-achalasia motility disorders of the esophagus. Surg Endosc 2019; 33: 1632-1639
• 8 Okeke FC, Raja S, Lynch KL. et al. What is the clinical significance of esophagogastric junction outflow obstruction? evaluation of 60 patients at a tertiary referral center. Neurogastroenterol Motil; 2017
• 9 Teitelbaum EN, Dunst CM, Reavis KM. et al. Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders. Surg Endosc 2018; 32: 421-427
• 10 Masadeh MM, Chandra S, Shen H. et al. Per-oral endoscopic myotomy for achalasia, esophagogastric junction outflow obstruction and diffuse esophageal spasm; a Us tertiary care center experience. Gastrointest Endosc 2017; AB579-AB580
• 11 Khashab MA, Familiari P, Draganov PV. et al. Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study. Endosc Int Open 2018; 6: E1031-e1036
• 12 Carlson DA, Kahrilas PJ, Lin Z. et al. Evaluation of esophageal motility utilizing the functional lumen imaging probe (FLIP). Am J Gastroenterol 2016; 111: 1726-1735
• 13 Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology 1992; 103: 1732-1738
• 14 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
• 15 Inoue H, Minami H, Kobayashi Y. et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 2010; 42: 265-271
• 16 Pereira PF, Rosa AR, Mesquita LA. et al. Esophagogastric junction outflow obstruction successfully treated with laparoscopic Heller myotomy and Dor fundoplication: First case report in the literature. World J Gastrointest Surg 2019; 11: p. 112-116
• 17 Samo S, Qayed E. Esophagogastric junction outflow obstruction: Where are we now in diagnosis and management?. World J Gastroenterol 2019; 25: 411-417
• 18 Schupack D, Katzka DA, Geno DM. et al. The clinical significance of esophagogastric junction outflow obstruction and hypercontractile esophagus in high resolution esophageal manometry. Neurogastroenterol Motil 2017; 29: 1-9
• 19 Clayton SB, Patel R, Richter JE. Functional and anatomic esophagogastic junction outflow obstruction: manometry, timed barium esophagram findings, and treatment outcomes. Clin Gastroenterol Hepatol 2016; 14: 907-911
• 20 Roman S, Gyawali CP, Xiao Y. et al. The Chicago classification of motility disorders: an update. Gastrointest Endosc Clin N Am 2014; 24: 545-561
• 21 Song BG, Min YW, Lee H. et al. Clinicomanometric factors associated with clinically relevant esophagogastric junction outflow obstruction from the Sandhill high-resolution manometry system. Neurogastroenterol Motil 2018; 30